Editorial Board — Medscape Rheumatology

Board Members

  • Stephen Paget, MD
    • Weill Cornell Medical College
      Hospital for Special Surgery
      New York, New York
  • Sergio Schwartzman, MD
    • Weill Cornell Medical College
      Hospital for Special Surgery
      NewYork-Presbyterian Hospital
      New York, New York
 

Board Member Details

Robert I. Fox, MD, PhD
Robert I. Fox, MD, PhD

Chief, Rheumatology Clinic, Scripps Memorial Hospital/XiMED, La Jolla, California

Robert I. Fox, MD, PhD, has disclosed the following relevant financial relationships:
Serve(d) as a director, officer, partner, employee, advisor, consultant, or trustee for: Allergan, Inc.; Celgene Corporation; Arena Pharmaceuticals, Inc.; Roche
Received income in an amount equal to or greater than $250 from: Celgene Corporation; Arena Pharmaceuticals, Inc.

Jonathan Kay, MD
Jonathan Kay, MD

Professor of Medicine & Timothy S. and Elaine L. Peterson Chair in Rheumatology, Division of Rheumatology, Department of Medicine, University of Massachusetts Medical School; Physician, Division of Rheumatology, Department of Medicine, UMass Memorial Medical Center, Worcester, Massachusetts

Jonathan Kay, MD, has disclosed the following relevant financial relationships:
Serve(d) as a consultant for: Amgen Inc; AbbVie Inc; Boehringer Ingelheim Pharmaceuticals, Inc. GmbH; Bristol-Myers Squibb; Crescendo Bioscience, Inc; Eli Lilly & Co; Fast Forward Pharmaceuticals, B.V.; Genentech, Inc; GlaxoSmithKline PLC; Janssen Biotech, Inc; Merck Sharp & Dohme Corp.; Novartis Pharmaceuticals Corporation; Pfizer, Inc; Samsung Bioepis; Sandoz Inc; Roche Laboratories, Inc.; UCB, Inc
Received research grant from: AbbVie, Inc; Ardea Bioscienses, Inc; Eli Lilly and Company; Pfizer, Inc; Genentech, Inc; Roche Laboratories, Inc.; UCB, Inc
Received an income in an amount equal to or greater than $250 from: Amgen Inc; AbbVie Inc; Boehringer Ingelheim Pharmaceuticals, Inc. GmbH; Bristol-Myers Squibb; Crescendo Bioscience, Inc; Eli Lilly & Co; Fast Forward Pharmaceuticals, B.V.; Genentech, Inc; GlaxoSmithKline PLC; Janssen Biotech, Inc; Merck Sharp & Dohme Corp.; Novartis Pharmaceuticals Corporation; Pfizer, Inc; Samsung Bioepis; Sandoz Inc; Roche Laboratories, Inc.; UCB, Inc

Muhammad A. Khan, MD, FRCP, MACP
Muhammad A. Khan, MD, FRCP, MACP

Professor Emeritus of Medicine, Case Western Reserve University; Staff Physician, Division of Rheumatology, MetroHealth Medical Center, Cleveland, Ohio

Muhammad A. Khan, MD, has disclosed the following relevant financial relationships:
Serve(d) as a consultant for: AbbVie Inc.; Novartis Pharmaceuticals Corporation; Eli Lilly and Company
Serve(d) as a speaker or a member of a speakers bureau for: AbbVie Inc.; Novartis Pharmaceuticals Corporation
Received income in an amount equal to or greater than $250 from: AbbVie Inc.; Novartis Pharmaceuticals Corporation

Stephen Paget, MD
Stephen Paget, MD

Professor of Medicine, Weill Cornell Medical College; Physician-in-Chief Emeritus, Center for Rheumatology, Hospital for Special Surgery, New York, New York

Stephen Paget, MD, has disclosed no relevant financial relationships.

Sergio Schwartzman, MD
Sergio Schwartzman, MD

Franchellie M. Cadwell Associate Professor of Clinical Medicine, Weill Cornell Medical College; Associate Attending Physician, Hospital for Special Surgery, NewYork-Presbyterian Hospital, New York, New York

Sergio Schwartzman, MD, has disclosed the following relevant financial relationships:
Serve(d) as a consultant for: Genentech BioOncology; Ortho-McNeil-Janssen Pharmaceuticals, Inc.; AbbVie Inc.; Pfizer Inc.; Epirus Biopharmaceuticals; Hospira, Inc.; Novartis Pharmaceuticals Corporation; Regeneron Pharmaceuticals, Inc.; Crescendo Bioscience, Inc..; Eli Lilly and Company; sanofi-aventis
Served as a board member for: Discus Analytics, LLC; National Psoriasis Foundation
Served on the scientific advisory board for: Crescendo Bioscience, Inc.;
Serve(d) as a speaker or member of a speakers bureau for: Genentech BioOncology; Ortho-McNeil-Janssen Pharmaceuticals, Inc.; AbbVie Inc.; Crescendo Bioscience, Inc.; Pfizer Inc.; Hospira, Inc.; Novratis Pharmaceuticals Corporation; sanofi-aventis; Regeneron Pharmaceuticals, Inc.; UCB Pharma, Inc.
Has stock in: Pfizer Inc.; Medtronic, Inc.; Amgen Inc.; Gilead Sciences, Inc.